Open Access

Hypermethylation of tumor necrosis factor decoy receptor gene in non‑small cell lung cancer

  • Authors:
    • Yuanlin Qi
    • Lin Qi
    • Minglian Qiu
    • Caiyun Yao
    • Mingfang Zhang
    • Jianbo Lin
    • Zhonghua Zheng
    • Chujia Chen
    • Hongxiang Li
    • Shiwei Duan
  • View Affiliations

  • Published online on: April 22, 2020     https://doi.org/10.3892/ol.2020.11565
  • Pages: 155-164
  • Copyright: © Qi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Abnormal methylation of the TNFRSF10C and TNFRSF10D genes has been observed in numerous types of cancer; however, no studies have investigated the methylation of these genes in non‑small cell lung cancer (NSCLC). The aim of the present study was to investigate the association between TNFRSF10C and TNFRSF10D methylation and NSCLC. Methylation levels of 44 pairs of NSCLC tumor tissues and distant non‑tumor tissues were analyzed using quantitative methylation specific PCR and methylation reference percentage values (PMR). The methylation levels of the TNFRSF10C gene in NSCLC tumor tissue samples were significantly higher compared with those in the distant non‑tumor tissues (median PMR, 2.73% vs. 0.75%; P=0.013). Subgroup analysis demonstrated that the methylation levels of TNFRSF10C in tumor tissues from male patients were significantly higher compared with those in distant non‑tumor tissues (median PMR, 2.73% vs. 0.75%; P=0.041). The levels of TNFRSF10C methylation were also higher in the tumor tissues of patients who were non‑smokers compared with their distant non‑tumor tissues (median PMR, 2.50% vs. 0.63%; P=0.013). TNFRSF10C methylation levels were higher in the tumor tissues from male patients compared with those from female patients (median PMR, 2.50% vs. 0.63%; P=0.031). However, no significant differences in the methylation levels of the TNFRSF10D gene were observed between the sexes. Using the cBioPortal and The Cancer Genome Atlas lung cancer data, it was demonstrated that TNFRSF10C methylation levels were inversely correlated with TNFRSF10C mRNA expression levels (r=‑0.379; P=0.008). In addition, demethylation of lung cancer cell lines A549 and NCI‑H1299 using 5'‑aza‑deoxycytidine further confirmed that TNFRSF10C hypomethylation was associated with significant upregulation of TNFRSF10C mRNA expression levels [A549 fold‑change (FC)=8; P=1.0x10‑4; NCI‑H1299 FC=3.163; P=1.143x10‑5]. A dual luciferase reporter gene assay was also performed with the insert of TNFRSF10C promoter region, and the results revealed that the TNFRSF10C gene fragment significantly enhanced the transcriptional activity of the reporter gene compared with that in the control group (FC=1.570; P=0.032). Overall, the results of the present study demonstrated that hypermethylation of TNFRSF10C was associated with NSCLC.
View Figures
View References

Related Articles

Journal Cover

July-2020
Volume 20 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qi Y, Qi L, Qiu M, Yao C, Zhang M, Lin J, Zheng Z, Chen C, Li H, Duan S, Duan S, et al: Hypermethylation of tumor necrosis factor decoy receptor gene in non‑small cell lung cancer. Oncol Lett 20: 155-164, 2020
APA
Qi, Y., Qi, L., Qiu, M., Yao, C., Zhang, M., Lin, J. ... Duan, S. (2020). Hypermethylation of tumor necrosis factor decoy receptor gene in non‑small cell lung cancer. Oncology Letters, 20, 155-164. https://doi.org/10.3892/ol.2020.11565
MLA
Qi, Y., Qi, L., Qiu, M., Yao, C., Zhang, M., Lin, J., Zheng, Z., Chen, C., Li, H., Duan, S."Hypermethylation of tumor necrosis factor decoy receptor gene in non‑small cell lung cancer". Oncology Letters 20.1 (2020): 155-164.
Chicago
Qi, Y., Qi, L., Qiu, M., Yao, C., Zhang, M., Lin, J., Zheng, Z., Chen, C., Li, H., Duan, S."Hypermethylation of tumor necrosis factor decoy receptor gene in non‑small cell lung cancer". Oncology Letters 20, no. 1 (2020): 155-164. https://doi.org/10.3892/ol.2020.11565